Zenuzolac

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameZenuzolac
Drug Alias NameGIT-27GIT-027VGX-1027GLS-1027
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsP38 mitogen-activated protein kinaseNuclear factor NF-kappa-B complex
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPuerto Rico +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGeneone Life Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesGeneone Life Science Inc
Inactive CompaniesVgx Pharmaceuticals Llc
Active IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A